Get started
Author

Teresa Cavero

Observed names: Cavero-Escribano,Teresa, T. CAVERO ESCRIBANO, T. Cavero, T. Cavero Escribano, T. Cavero-Escribano, Teresa Cavero Escribano, Teresa Cavero escribano, Teresa Cavero-Escribano
Observed institutions: Universitat Autònoma de Barcelona, Hospital Universitario de Canarias, Hospital Universitario La Paz, Instituto de Salud Carlos III, Research Institute Hospital 12 de Octubre, Hospital Universitario 12 De Octubre, Puigvert Foundation
ORCID: 0000-0001-5187-9906
Observed ORCID: 0000-0001-5187-9906
OpenAlex ID: A5024530998
Remission of Hematuria Improves Renal Survival in IgA Nephropathy
2017 · Angel M. Sevillano, Eduardo Gutiérrez, et al. · Journal of the American Society of Nephrology · 178
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
2023 · Lesley A. Inker, Willem Collier, et al. · Nature Medicine · 172
PDF
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
2015 · Cristina Rabasco, Teresa Cavero, et al. · Kidney International · 170
Eculizumab in secondary atypical haemolytic uraemic syndrome
2016 · Teresa Cavero, Cristina Rabasco, et al. · Nephrology Dialysis Transplantation · 165
PDF
A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome
2017 · Ana Huerta, Emilia Arjona, et al. · Kidney International · 161
PDF
RICORS2040: the need for collaborative research in chronic kidney disease
2021 · Alberto Ortiz, Marta Roger, et al. · Clinical Kidney Journal · 124
PDF
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy
2023 · Edwin Wong, Carla Nester, et al. · Kidney International Reports · 108
PDF
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome
2019 · Teresa Cavero, Emilia Arjona, et al. · Kidney International · 100
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease
2020 · Fernando Caravaca-Fontán, Montserrat M. Díaz-Encarnación, et al. · Clinical Journal of the American Society of Nephrology · 85
PDF
Update on C3 Glomerulopathy: A Complement-Mediated Disease
2020 · Fernando Caravaca-Fontán, Laura Lucientes, et al. · ˜The œNephron journals/Nephron journals · 79
Kidney transplant from uncontrolled donation after circulatory death donors maintained by nECMO has long-term outcomes comparable to standard criteria donation after brain death
2018 · María Molina, Félix Guerrero-Ramos, et al. · American Journal of Transplantation · 63
Validation of a Histologic Scoring Index for C3 Glomerulopathy
2020 · Fernando Caravaca-Fontán, Hernando Trujillo, et al. · American Journal of Kidney Diseases · 54
Thrombotic microangiopathy in patients with malignant hypertension
2022 · Teresa Cavero, Pilar Auñón, et al. · Nephrology Dialysis Transplantation · 49
Rituximab for treatment of severe renal disease in ANCA associated vasculitis
2015 · Duvuru Geetha, Zdenka Hruskova, et al. · Journal of Nephrology · 48
PDF
Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era
2020 · Ana Isabel Avila Bernabeu, Teresa Cavero Escribano, et al. · ˜The œNephron journals/Nephron journals · 39
C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies
2021 · Fernando Caravaca-Fontán, Laura Lucientes, et al. · Nephrology Dialysis Transplantation · 38
Circulating C3 levels predict renal and global outcome in patients with renal vasculitis
2016 · Javier Villacorta, Francisco Diaz-Crespo, et al. · Clinical Rheumatology · 37
The predictive value of kidney biopsy in renal vasculitis: a multicenter cohort study
2016 · Francisco Diaz-Crespo, Javier Villacorta, et al. · Human Pathology · 32
Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis
2023 · Laura Lucientes-Continente, Gema Fernández-Juárez, et al. · Kidney International · 26
PDF
Characteristics, management and outcomes of atypical haemolytic uraemic syndrome in kidney transplant patients: a retrospective national study
2020 · José Portoles, Ana Huerta, et al. · Clinical Kidney Journal · 26
PDF
Long-term validation of the renal risk score for vasculitis in a Southern European population
2020 · Javier Villacorta, Francisco Diaz-Crespo, et al. · Clinical Kidney Journal · 26
PDF
Urinary soluble CD163 as a biomarker of disease activity and relapse in antineutrophil cytoplasm antibody-associated glomerulonephritis
2020 · Javier Villacorta, Laura Lucientes, et al. · Clinical Kidney Journal · 25
PDF
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
2023 · Fernando Caravaca-Fontán, Teresa Cavero, et al. · Kidney360 · 23
IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy
2022 · Hernando Trujillo, Justo Sandino, et al. · Kidney International Reports · 22
Malignant hypertension: a type of IgA nephropathy manifestation with poor prognosis.
2015 · Ángel M Sevillano, Jimena Cabrera, et al. · PubMed · 18
Works count: 101
Citation count: 2,071
H-index: 23
I10-index: 31
Year
Topic
Type